Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nehal S. Parikh
Observed names:
N. Parikh,
N.S. Parikh,
Nehal Parikh,
Nehal S Parikh,
Nehal S. Parikh
Institutions:
Rutgers, The State University of New Jersey,
Rutgers Cancer Institute
Observed institutions:
Rutgers, The State University of New Jersey,
Cincinnati Children's Hospital Medical Center,
Connecticut Children's Medical Center,
Rutgers Cancer Institute,
Rutgers New Jersey Medical School,
University of Cincinnati
show all 6
ORCID:
0000-0002-4746-1168
Observed ORCID:
0000-0002-4746-1168
OpenAlex ID:
A5011933117
Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate
2008
·
Krishnan Venkataraman
, Yong-Moon Lee
, et al.
·
Circulation Research
·
537
PDF
Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins
2007
·
Kotaro Takeda
, Hector L. Aguila
, et al.
·
Blood
·
288
PDF
Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient
2006
·
Krishnan Venkataraman
, Shobha Thangada
, et al.
·
Biochemical Journal
·
230
PDF
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
2015
·
Giselle L. Saulnier Sholler
, Eugene W. Gerner
, et al.
·
PLoS ONE
·
152
PDF
SIOP‐PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low‐ and middle‐income settings
2015
·
Nehal S. Parikh
, Scott C. Howard
, et al.
·
Pediatric Blood & Cancer
·
126
PDF
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
2018
·
Giselle L. Saulnier Sholler
, William Ferguson
, et al.
·
Scientific Reports
·
116
PDF
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
2021
·
Kevin Conlon
, Dionysios C Watson
, et al.
·
Journal for ImmunoTherapy of Cancer
·
57
PDF
A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome
2022
·
Courtney D. DiNardo
, Andreas Hochhaus
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
43
Oncolytic herpes simplex virus mutants are more efficacious than wild‐type adenovirus Type 5 for the treatment of high‐risk neuroblastomas in preclinical models
2004
·
Nehal S. Parikh
, Mark A. Currier
, et al.
·
Pediatric Blood & Cancer
·
42
Feasibility of implementing molecular‐guided therapy for the treatment of patients with relapsed or refractory neuroblastoma
2015
·
Giselle L. Saulnier Sholler
, Jeffrey P. Bond
, et al.
·
Cancer Medicine
·
29
PDF
Global Neuroblastoma Network: An international multidisciplinary neuroblastoma tumor board for resource‐limited countries
2022
·
Katherine K. Matthay
, Jennifer Hylton
, et al.
·
Pediatric Blood & Cancer
·
19
A Pilot Trial Testing the Feasibility of Using Molecular-Guided Therapy in Patients with Recurrent Neuroblastoma
2012
·
Giselle L. Saulnier Sholler
, William Ferguson
, et al.
·
Journal of Cancer Therapy
·
19
PDF
A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies
2024
·
G. Curigliano
, M.M. Jimenez
, et al.
·
ESMO Open
·
14
Abstract CT103: Phase I study of LHC165 ± spartalizumab (PDR001) in patients (pts) with advanced solid tumors
2021
·
Giuseppe Curigliano
, Miguel Martin Jimenez
, et al.
·
Cancer Research
·
12
Abstract 4128: Identification and characterization of LHC165, a TLR7 agonist designed for localized intratumoral therapies
2019
·
Jonathan A. Deane
, German A. Cortez
, et al.
·
Cancer Research
·
10
Descriptive analysis of tumor cells with stem like phenotypes in metastatic and benign adrenal tumors
2015
·
Todd Jensen
, Stephanie Vadasz
, et al.
·
Journal of Pediatric Surgery
·
10
A Case Report: Jacobsen Syndrome Complicated by Paris-Trousseau Syndrome and Shone’s Complex
2015
·
Laurie A. Malia
, Leslie I. Wolkoff
, et al.
·
Journal of Pediatric Hematology/Oncology
·
7
Primary renal synovial sarcoma in a 13-year-old boy
2011
·
Kristen R. Scarpato
, John H. Makari
, et al.
·
Journal of Pediatric Surgery
·
7
A young girl with hemolytic anemia and elevated hemoglobin F
2004
·
Nehal S. Parikh
, James D. Hoyer
, et al.
·
Pediatric Blood & Cancer
·
4
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor
2023
·
Shruti Lal
, Neil E. Bhola
, et al.
·
Cancer Research Communications
·
3
PDF
Abstract CT082: Phase (Ph) I/Ib study of NIZ985 with and without spartalizumab (PDR001) in patients (pts) with metastatic/unresectable solid tumors
2019
·
Kevin Conlon
, Rom Leidner
, et al.
·
Cancer Research
·
3
Abstract CT082: Phase (Ph) I/Ib study of NIZ985 with and without spartalizumab (PDR001) in patients (pts) with metastatic/unresectable solid tumors
2019
·
Kevin Conlon
, Rom Leidner
, et al.
·
Clinical Trials
·
2
Abstract LB-179: Phase I trial of relapsed neuroblastoma with DFMO alone and in combination with etoposide.
2013
·
Giselle L. Sholler
, Eugene W. Gerner
, et al.
·
Cancer Research
·
2
Locoregional and systemic adoptive cellular therapies for pediatric brain tumors: a systematic review of CAR‑T, TCR‑engineered T cells, and NK cell strategies
2026
·
Yaxel Levin Carrion
, Jayant Bhasin
, et al.
·
Neurosurgical Review
·
1
PDF
Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors?
2026
·
Yaxel Levin-Carrion
, Jayant Bhasin
, et al.
·
Journal of Neuro-Oncology
·
1
PDF
Show more works
View as search
Works count:
75
Citation count:
1,738
H-index:
13
I10-index:
16
Year
Topic
Type